Breast cancer recurrence risk in relation to antidepressant use after diagnosis.
about
Threats to validity of nonrandomized studies of postdiagnosis exposures on cancer recurrence and survivalAn indicator of cancer: downregulation of monoamine oxidase-A in multiple organs and species.Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort studyChange in lifestyle behaviors and medication use after a diagnosis of ductal carcinoma in situ.Administrative data algorithms to identify second breast cancer events following early-stage invasive breast cancerCYP2D6 inhibition and breast cancer recurrence in a population-based study in Denmark.Use of antidepressants and NSAIDs in relation to mortality in long-term breast cancer survivors.Metabolism and transport of tamoxifen in relation to its effectiveness: new perspectives on an ongoing controversyClinical epidemiology and pharmacology of CYP2D6 inhibition related to breast cancer outcomes.Breast cancer recurrence in relation to antidepressant use.The influence of travel time on breast cancer characteristics, receipt of primary therapy, and surveillance mammography.Effect of selective serotonin reuptake inhibitors use on endocrine therapy adherence and breast cancer mortality: a population-based study.Tamoxifen and Antidepressant Drug Interaction in a Cohort of 16,887 Breast Cancer SurvivorsApplication of Mice Humanized for CYP2D6 to the Study of Tamoxifen Metabolism and Drug-Drug Interaction with AntidepressantsFactors associated with long-term adherence to annual surveillance mammography among breast cancer survivors.Using natural language processing to improve efficiency of manual chart abstraction in research: the case of breast cancer recurrence.Clinically relevant drug interactions in anxiety disorders.Hot flushes in women with breast cancer: state of the art and future perspectives.First-onset mental disorders after cancer diagnosis and cancer-specific mortality: a nationwide cohort study.Evidence for Detection Bias by Medication Use in a Cohort Study of Breast Cancer Survivors.Selective serotonin reuptake inhibitors and adjuvant tamoxifen therapy: risk of breast cancer recurrence and mortality.Concurrent use of tamoxifen with CYP2D6 inhibitors and the risk of breast cancer recurrence.Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study.Antidepressant use and risk of central nervous system metastasis.How often did Belgian physicians co-prescribe tamoxifen with strong CYP2D6 inhibitors over the last 6 years?
P2860
Q27022747-AE9B6A71-2170-49A2-99EE-A2AE0CFF2964Q33325705-48794877-6E64-46C0-AFAD-307F84E4F570Q33634928-6998D996-9D3F-4F3B-B179-F2F23E43A9B5Q34077062-B6809866-7551-4770-B4F4-EE81F8065DA7Q34252411-CE3AF6FB-8B2C-4850-85E5-832AB4BB6FEBQ34677193-4AD17569-2FF8-4DD4-BA23-5569C8E7556BQ34778824-8D35A98A-DE80-4825-9C4E-8FDF6B97BC1DQ35056229-16EABC7E-3617-4F91-B3F1-929A98980C16Q35058455-76FE94DC-51A4-4CF4-A0FA-FF423A09376CQ37020150-CC737A38-6704-4B8F-B8F4-B1220ADB78A1Q37205390-BD697356-77AD-46EE-A3D4-D60F743C8D0CQ37233775-1D36ECEF-CFFA-4693-AE3E-A3B962166D29Q37353826-4E15A9D1-55EA-45E9-9BDC-F1298D7CE3F1Q37540176-7FB25556-239C-4303-AEBD-4F3DDF56380EQ37604566-946E594C-6E16-40F0-9B88-DC980A8413F1Q37612592-0449A997-A761-4D14-BAD4-A32D9188E70BQ37981951-EE0ACC79-BB2D-48D9-8E01-822269EA7962Q38169220-55A72D2A-6027-40F6-AD73-B88498A4C492Q38400919-D3E15302-DA49-4AAD-B200-1B08896B131BQ38879569-E736A131-0F83-4078-8488-01EE077DCC02Q43042856-939D70F1-0FDF-42B7-9564-B7699AE3BCBAQ44849364-1BCAB4DB-8B1C-4485-B96B-8EBFFFD0567FQ47651513-CCC5861B-8E36-48E3-9EC7-D2B444076953Q48682791-F316A8C5-D2F9-405A-833F-16B5051CA544Q50709557-E4B885BD-A641-4683-9916-37DB1ACEFFF4
P2860
Breast cancer recurrence risk in relation to antidepressant use after diagnosis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Breast cancer recurrence risk in relation to antidepressant use after diagnosis.
@ast
Breast cancer recurrence risk in relation to antidepressant use after diagnosis.
@en
type
label
Breast cancer recurrence risk in relation to antidepressant use after diagnosis.
@ast
Breast cancer recurrence risk in relation to antidepressant use after diagnosis.
@en
prefLabel
Breast cancer recurrence risk in relation to antidepressant use after diagnosis.
@ast
Breast cancer recurrence risk in relation to antidepressant use after diagnosis.
@en
P2093
P2860
P1476
Breast cancer recurrence risk in relation to antidepressant use after diagnosis.
@en
P2093
Denise M Boudreau
Diana S M Buist
Jessica Chubak
Noel S Weiss
Thomas Lumley
P2860
P2888
P304
P356
10.1007/S10549-007-9828-9
P407
P577
2007-12-06T00:00:00Z